Effect of miRNA-138 Injected into the Medial Habenula on Nicotine Intake and Preference by Fitzgerald, Kelsey
University of Colorado, Boulder
CU Scholar
Undergraduate Honors Theses Honors Program
Spring 2015
Effect of miRNA-138 Injected into the Medial
Habenula on Nicotine Intake and Preference
Kelsey Fitzgerald
Kelsey.Fitzgerald@Colorado.EDU
Follow this and additional works at: http://scholar.colorado.edu/honr_theses
Part of the Behavioral Neurobiology Commons, Developmental Biology Commons, Genetics
Commons, and the Molecular Biology Commons
This Thesis is brought to you for free and open access by Honors Program at CU Scholar. It has been accepted for inclusion in Undergraduate Honors
Theses by an authorized administrator of CU Scholar. For more information, please contact cuscholaradmin@colorado.edu.
Recommended Citation
Fitzgerald, Kelsey, "Effect of miRNA-138 Injected into the Medial Habenula on Nicotine Intake and Preference" (2015).
Undergraduate Honors Theses. Paper 842.
 Effect of miRNA-138 Injected into the Medial Habenula 
on Nicotine Intake and Preference  
 
 
By: 
Kelsey Fitzgerald 
Department of Integrative Physiology, University of Colorado at Boulder 
 
 
 
 
Defended April 2, 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis Advisor: 
Dr. Marissa Ehringer, Dept. of Integrative Physiology 
Honors Council Representative: 
Dr. David Sherwood, Dept. of Integrative Physiology 
Defense Committee: 
Dr. Ryan Bachtell, Dept. of Psychology  
1 
 
Abstract 
 Nicotine is one of the most commonly abused drugs in the world today and is associated 
with many adverse health outcomes, including death. Nicotine binds to nicotinic acetylcholine 
receptors (nAChRs) in the brain reward pathway, triggering the release of a number of 
neurotransmitters, including dopamine.  The goal of the current study was to determine whether 
miR-138, a miRNA that targets and reduces β4 subunit gene expression, injected into the medial 
habenula would lead to changes in nicotine intake/preference. We hypothesized that miR-138 
would down regulate β4 expression, leading to decreased aversion to nicotine and increased 
nicotine intake/preference. Male and female C57BL/6 mice were unilaterally injected with an 
adeno-associated virus containing either miR-138 or a scrambled control miRNA sequence.  
Mice were then given access to water and increasing concentrations of a nicotine solution. We 
measured overall fluid consumption as well as nicotine intake. Mice injected with the miR-138 
showed a trend for reduced nicotine intake and consumption compared to controls. Preliminary 
results were not statistically significant, but suggest that miR-138 injected into the medial 
habenula does not affect nicotine intake/preference. The current results suggest that reducing the 
expression of β4 subunits in the medial habenula via miR-138 leads to reductions in nicotine 
reward-related behavior, which does not support our initial hypothesis.  
 
Introduction  
  Tobacco use is the number one cause of preventable deaths in the United States, and 
each year an estimated 443,000 people die prematurely from smoking (CDC, 2011). Nicotine is 
the major psychoactive chemical in tobacco, and repeated exposure to nicotine often results in 
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nicotine dependence. Nicotine dependence includes many different features, where a primary 
component is the inability to stop using the substance (CDC, 2010). Nicotine induces physical 
and mood-altering effects that are rewarding to the user (depending on dose), which in turn 
perpetuates nicotine intake (Baker, 2012). Stopping use of the substance will result in physical 
withdrawal symptoms including anxiety, depression, and headaches (Baker, 2012). In the United 
States, nicotine dependence has a prevalence of 24.1% with the onset commonly occurring 
before the age of 25 and dependence continuing on well into the 40s (Breslau et al., 2001). 
Nicotinic Acetylcholine Receptors  
Nicotine binds to nicotinic acetylcholine receptors (nAChRs) in the brain. Nicotinic 
acetylcholine receptors are heteropentamer cholinergic receptors, consisting of five membrane 
proteins (subunits) that surround a pore in the middle, forming ligand-gated ion channels in the 
plasma membranes of neurons. Receptors are formed from a various combinations of α, β, Δ, and 
γ subunits (Albuquerque et al., 2009). In the brain only α2-α9 and β2-β4 subunits are expressed 
(Picciotto et al., 2000), and these subunits are free to interact, but not all subunit combinations 
will result in a nicotine binding site.  
Of particular interest to the current project are the α3, α5 and β4 subunits because they 
are enriched in the habenulo-interpeduncular (Hb-IPN) midbrain pathway, a pathway implicated 
in the aversive effects of nicotine, and nicotine withdrawal (Antolin-Fontes et al., 2014). Further, 
the CHRNA5-A3-B4 gene cluster encodes α5, α3 and β4 subunits and has been associated with 
vulnerability to tobacco dependence in human genetics studies (Bierut et al., 2008 and 
MacKillop et al., 2010).  
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β4 subunit and microRNAs involvement in nicotine dependence  
This study focuses on the β4 subunit because the α5 subunit, although it co-assembles 
with α3β4, does not play a role in nicotine withdrawal and acute nicotine behaviors (Jackson et 
al., 2013). The β4 subunit, on the other hand, is highly involved in nicotine aversion (Baldwin, 
Alanis and Salas, 2011). For example, β4 knockout (KO) mice and α5 KO mice have fewer 
somatic signs of withdrawal compared to controls following chronic nicotine administration and 
attenuated withdrawal-induced hyperalgesia (Jackson et al., 2008 and Salas et al., 2009). 
Similarly, chronic nicotine treatment upregulates β4 gene expression in neurons of the Hb-IPN 
and infusion of the β4 nAChR antagonist SR16584 in the Hb-IPN elicited somatic signs of 
nicotine withdrawal (Zhao-Shea et al., 2013).   
Along with the apparent role of the β4 subunit in nicotine withdrawal, recent findings 
also implicated β4 in aversive responses to nicotine. For example, overexpression of β4 in the 
medial habenula produced nicotine aversion in mice (Slimak et al., 2014). Further, voltage-clamp 
recoding showed that human β4 genetic variants that increased nicotine-induced current flow 
also increased aversion to nicotine in a two-bottle choice nicotine preference study.  Variants that 
decreased nicotine-induced currents, on the other hand, also decreased aversion (Slimak et al., 
2014). The role of β4 subunits in nicotine aversion and withdrawal implicated the subunit in 
nicotine addiction/dependence, and thus assessing how endogenous genetic regulatory 
mechanisms that may modulate nicotine reward is important to developing treatment options for 
nicotine dependence. One genetic regulatory mechanism that is gaining a lot of attention recently 
is a family of RNAs called microRNAs (miRNAs). 
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MicroRNAs (miRNAs) are endogenous small (22 nucleotides) non-coding RNAs that 
target the 3’-untranslated region of mRNA to regulate gene expression post-transcriptionally. 
Over 1000 miRNAs have been identified in humans, and more than a third of all genes are 
regulated by miRNAs (Bartel et al., 2009). Since the discovery of miRNAs, a growing body of 
evidence implicates miRNAs in a number of neurological diseases, including addiction (Li and 
van der Vaart, 2011). MiRNAs have shown to play roles in the modification of the reward 
system in the brain that drives addiction due to drugs (Bali and Kenny, 2013). Relevant to the 
current project, nicotine can produce changes in miRNA expression, suggesting that nicotine can 
regulate miRNAs expression (Taki, Pan, and Zhang, 2014), and thus this change in miRNAs may 
facilitate changes in nAChR subunit expression, ultimately influencing the development of 
nicotine dependence/addiction. Recently, our lab showed that a specific miRNA, miR-138, leads 
to decreased gene expression using an in vitro luciferase assay targeting the 3’UTR of the human 
CHRNB4 gene (Gallego, 2013), and is only expressed in brain tissue.  
Purpose and Hypothesis 
Given the importance of β4 receptor subunits in nicotine dependence/addiction, and the 
recent finding from our lab that miR-138 reduces gene expression of a vector containing the 
3’UTR of CHRNB4 in vitro, we were interested to assess the effects of miR-138, injected 
unilaterally into the medial habenula, on two-bottle choice nicotine intake/preference.  Because 
of the medial habenula’s involvement in nicotine withdrawal (Zhao, Tapper, 2013), and the 
enrichment of β4 containing nAChRs in the medial habenula, we predicted that injecting 
miRNA-138 into the medial habenula would down-regulate β4 subunits and result in increased 
nicotine intake/preference.  
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Methods 
Animals 
 Male and female C57BL/6J mice were purchased from Jackson Laboratories. Mice 
arrived at the Institute for Behavioral Genetics at 7 weeks of age and were housed 2-5 per cage 
during the 7-day acclimation period with ad libitum access to food and water. Following 
stereotaxic surgery (see below), mice were singly housed with ad libitum access to food and 
water and given a two-week period for miRNAs to have an effect. Experiments we performed on 
a 12:12 light cycle approved by the University of Colorado at Boulder Institutional Animal Care 
and Use Committee with the lights off at 1900 hours.  
Adeno-Associated Viral vectors 
 Adeno-Associated Viral vectors were purchased from Vectors Biolabs (Philadelphia, PA) 
and were used for delivery of miR-138 into the brain. Procedure of administration is outlined in 
the surgery section below. 
Nicotine Solutions 
Nicotine solutions were made of free-base nicotine and diluted to the desired 
concentration of 25, 50, 100 and 200 ug/mL with tap water. The Nicotine was purchased from 
Sigma-Aldrich, St. Louis, MO.  
Surgery  
Mice (60 days old) were anesthetized with 100/10 mg/kg of Ketamine/Xylazine 
administered by IP injection. Duratears ophthalmic ointment (1 drop) was administered topically 
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to protect their corneas. Adeno-Associated Virus (AAV) was administered through 
microinjections under the approved IACUC protocol. An incision was made in the scalp and a 
burr hole in the skull, positioned to expose the injection site above the medial habenula The 
coordinates are X= 0.35, Y= -1.74, Z= 3.2 for males, and X= 0.35, Y= -1.50, Z= 3.2 for females. 
A Hamilton syringe needle (31 gauge), with AAV containing either miR-138 or a scrambled 
control miRNA, was injected into the medial habenula at a rate 0.1 mL/min totaling 0.5-1 mL. 
Green Fluorescent Protein (GFP) was injected along with the AAV and was used as a visible 
marker. Mice with either treatment received an injection of GFP to later verify the location of the 
injection into the MHb. 0.05-0.1 mg/kg of Buprenorphine and 100 mg/kg Penicillin (Twin-Pen) 
were administered through a subcutaneous injection to prevent infection following the procedure. 
The body temperature of the mice was maintained with a heating pad for the first 1-2 hours 
during recovery from anesthesia. The mice were monitored every 12 hours following surgery for 
the first 48 hours. 
Nicotine Preference Study 
 Mice were given a nicotine two bottle choice paradigm and observed for 16 days as the 
concentration of the nicotine was increased. Following the 2-week period after AAV injection, 
standard water bottles were replaced with two test tubes fitted with drinking spouts (drinking 
tubes), one containing tap water and one containing increasing concentrations of nicotine (25 to 
50, 100, and 200 ug/mL) diluted with tap water. The drinking amounts were observed by 
measuring the difference in volume over the 24 hour period. Nicotine concentrations were 
increased every four days. The side the nicotine was alternated every two days to avoid 
development of a side preference. The mice were weighed on the first day of each concentration 
increase (every four days) to ensure good health and to standardize the nicotine consumed by 
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body weight. Evaporation/leakage was accounted for using tubes placed in empty cages, and the 
mean volume loss was subtracted from the individual drinking values. Cages were changed every 
7-days after drinking measurements were taken. 
Statistical Analysis 
 For all animal data, statistical analyses were performed using SPSS. Data (total volume, 
nicotine preference, and nicotine consumption) were analyzed using Analysis of Variance 
(ANOVA) with Treatment and Sex as the between subject factors, and nicotine concentration 
and day as the within subject factors. P≤0.05 were considered significant. Analysis of each 
dependent variable was done two ways for each item of collected data, the first being the 
collapsed across all four days per concentration, and the second way was by isolating days two 
and four per concentration (e.g. days 2 and 4 for 25ug/mL, days 6 and 8 for 50ug/mL , days 10 
and 12 for 100ug/mL, and days 14 and 16 for 200ug/mL). We ran the analysis both ways 
because drinking behavior is influenced by stress, and by isolating days 2 and 4 of each 
concentration we reduced the variability in the behavioral data associated with the stress of 
handling the mice.  
Total volume consumed was measured as the overall consumption of nicotine and water. 
Nicotine preference was calculated as the percent of nicotine consumed of the total volume. 
Nicotine Consumption was measured by the amount of nicotine consumed at the concentration 
and then standardized by each animal’s body weight. Significant interactions uncovered from the 
omnibus ANOVA were followed up with lower-order ANOVAs and post hoc t-tests where 
appropriate.  
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Results 
Total Volume Consumed Results 
Intake averaged across concentration 
A)  
B)    C) 
Figure 1: The total volume of both nicotine and water consumed for the four different nicotine 
concentrations tested. Data are shown collapsed by sex (A), and split into males (B) and females 
(C).  
Figure 1 shows the amount of total volume consumed (mL) for each experimental group, 
collapsed across concentration days. Three-way ANOVA (Concentration x Sex x Treatment) of 
total volume indicated a main effect of sex only [F(1,30)=9.7, p<0.01)], showing that males 
drank more total fluid than females. The main effect of treatment did not reach significance 
(p=0.276). Analyses also uncovered a Concentration x Sex x Treatment interaction [F(3,90)=3.8, 
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p=0.012], but follow-up analyses within sex indicated no significance [Female: F(1,20)=2.3, 
p=0.148; Male: F(1,10)= 0.14, p=0.716)]  
Intake averaged across days 2 & 4 of each concentration 
A)  
B)  C)
Figure 2: The total volume of both nicotine and water consumed for the four different nicotine 
concentrations tested averaged across days 2 and 4. Data are shown collapsed by sex (A), and 
split into males (B) and females (C).  
 
Figure 2 shows the amount of total volume consumed (mL) for each experimental group, 
collapsed across concentration days 2 and 4. Three-way ANOVA (Concentration x Sex x 
Treatment) of total volume indicated a main effect of sex only [F(1,30)=11.6, p<0.01)], showing 
that males drank more total fluid than females. The main effect of treatment did not reach 
significance (p=0.175). Analyses also uncovered a Concentration x Sex x Treatment interaction 
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[F(3,90)=3.4, p=0.021], but follow-up analyses within sex indicated no significance [Female: 
F(1,20)=3.3, p=0.085; Male: F(1,10)= 0.299, p=0.596)]  
Nicotine Preference Results  
Preference averaged across concentration  
A)  
B)   C)   
Figure 3: Nicotine Preference for the four different nicotine concentrations tested. Data are 
shown collapsed by sex (A), and split into males (B) and females (C). 
 
Figure 3 shows the nicotine preference (%) represented as a percentage of the total 
volume for each experimental group. Three-way ANOVA (Concentration x Sex x Treatment) of 
nicotine preference indicated a main effect of concentration only [F(3,90)=12.2, p<0.0001], 
showing that there was a higher preference at lower concentrations. The main effect of treatment 
did not reach significance (p=0.343). Analyses also uncovered a Concentration x Sex interaction 
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[F(3,90)=3.4, p=0.021]. Follow-up analyses comparing Sex at each concentration indicated the 
interaction was due to a significant main effect of Sex at the 50 ug/mL concentration only 
[F(1,32)=4.6, p=0.04].  
Preference averaged across days 2 & 4 of each concentration 
A)  
B)    C) 
Figure 4: Nicotine Preference for only days two and four for the four different nicotine 
concentrations tested. Data are shown collapsed by sex (A), and split into males (B) and females 
(C).  
Figure 4 shows the nicotine preference for days 2 and 4 (%) for each experimental group. 
Three-way ANOVA (Concentration x Sex x Treatment) of nicotine preference indicated a main 
effect of concentration only [F(3,90)=10.5, p<0.0001], showing that there was a higher 
preference at lower concentrations. The main effect of treatment did not reach significance 
(p=0.24). Analyses also uncovered a Concentration x Sex interaction [F(3,90)=2.8, p=0.043]. 
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Follow-up analyses within sex indicated no significance for male mice, and for female mice 
there was a main effect of concentration [F(3,63)=14.4, p<0.001] 
Nicotine Consumption Results  
Consumption averaged across concentration 
A)  
B)    C) 
Figure 5: Nicotine Consumed for the four different nicotine concentrations tested. Data are 
shown collapsed by sex (A), and split into males (B) and females (C).  
Figure 5 shows the nicotine consumed (mg/kg) for each experimental group. Three-way 
ANOVA (Concentration x Sex x Treatment) of nicotine preference indicated a main effect of 
concentration only [F(3,90)=22.5, p<0.01], showing that more nicotine per body weight was 
consumed at higher concentrations. The main effect of treatment did not reach significance 
(p=0.493). There was no initial significance between the treatment groups, so follow-up analysis 
was not run on the separated sexes. 
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Consumption averaged across days 2 & 4 of each concentration 
A)  
B)    C)  
Figure 6: Nicotine Consumed for only days two and four for the four different nicotine 
concentrations tested. Data are shown collapsed by sex (A), and split into males (B) and females 
(C).  
Figure 6 shows the nicotine consumed for days 2 and 4 (mg/kg) for each experimental 
group. Three-way ANOVA (Concentration x Sex x Treatment) of nicotine consumption 
indicated a main effect of concentration only [F(3,90)=16.3, p<0.001], showing that there was 
more nicotine consumed per body weight at higher concentrations. The main effect of treatment 
did not reach significance (p=0.34). The collapsed data showed no significance between 
treatments, so further analyses were not run on the separate sexes. 
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Consumption per day across the concentrations 
A)  
B)  
C)  
Figure 7: Nicotine Consumed per day. Data are shown collapsed by sex (A), and split into males 
(B) and females (C).  
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Figure 7 shows the nicotine consumed per individual day (mg/kg) for each experimental 
group. Three-way ANOVA (Concentration x Sex x Treatment) of nicotine preference indicated a 
main effect of concentration [F(3,90)=22.5, p<0.01], showing that more nicotine was consumed 
per body weight at higher concentrations. These results are the same for the averaged data across 
the concentrations days. Follow up analyses did not reach significance. 
Discussion 
 The purpose of the current study was to assess the involvement of β4 subunits in nicotine 
reward-related behaviors by using miR-138, which may be able to reduce the expression of β4 
nAChR subunits. We hypothesized that the down regulation of β4 subunits would result in an 
increase in nicotine intake/preference. MiR-138 is predicted to bind to β4 mRNA (Gallego, 
2013), resulting in decreased expression of the β4 subunit protein. The β4 subunit plays a role in 
nicotine aversion (Baldwin, Alanis and Salas, 2011), and when down regulating the β4 subunit 
we expected to see a decrease in aversion and consequently an increase in nicotine 
intake/preference. Our preliminary results suggest that miR-138 injected into the medial 
habenula leads to reduced consumption of nicotine, which did not support our hypothesis.   
Findings  
 During our analysis we observed a decrease in overall consumption of total volume for 
the miR-138 female mice (Figure 1, graph C). We also saw a decrease in nicotine consumption 
by the female miR-138 mice (Figure 5, graph C). Visually both show different consumptions 
than the control mice, but when looked at together we cannot say that the decrease in nicotine 
consumption for the miR-138 females mice is relevant when there was a general decrease in total 
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volume for the miR-138 females. Therefore we cannot say the effect was specific to nicotine 
without further preference analysis. 
 Although our statistical analyses found no statistical significance between treatment 
groups, there was evidence for differences within certain concentrations. Results showed that 
more nicotine was consumed per body weight at higher concentrations (Figure 5). This is 
consistent with previous work showing nicotine induces the reward pathway at higher doses 
(Fowler and Kenny, 2011) which may result in more consumption at the higher concentrations. 
For nicotine preference we observed that there was an increase in preference at lower 
concentrations (Figure 3). The mice tended to drink more of the diluted concentrations and less 
as the concentration increased. This agrees with the idea that more volume at a lower 
concentration is necessary to achieve desired levels of nicotine to activate the reward pathway 
(Baker et al., 2012).  
Sex differences also played a role in consumption and preference. Studies support our 
findings that sex plays a role in total volume consumption and nicotine consumption that is 
adjusted for body weight (Klein et al., 2004). Males consumed more volume overall than females 
(Figure 1), but did not consume more nicotine. For nicotine preference (Figure 4) the males 
showed no significance while the females had a statistical significant result between treatments. 
Males also had more variance in their consumption while females had a more consistent trend 
from day to day. Visual inspection of Figure 7 suggests that the observed interaction effect is due 
to males reducing intake of the 100 ug/mL nicotine concentration (days 9-12 in graph B) while 
females show consistent intake across the 100 ug/mL concentration days (days 9-12 graph C).  
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Based on previous studies (Chester et al., 2006), we anticipated that stress due to 
changing the bottles might alter the drinking behaviors. However, similarities visually and in our 
analyses between Figures 3 and 4 and Figures 5 and 6 shows that this stress did not affect 
drinking behaviors for both nicotine preference and nicotine consumption. The graphs isolating 
days two and four show the same results with similar values as the graphs representing all days 
collapsed. This indicates that the stress involved in changing bottles on days one and three did 
not affect the amount of nicotine consumed.  
We hypothesized that by potentially down regulating the β4 nAChRs with miR-138 we 
would see an increase in nicotine intake/preference. Surprisingly, our results suggest an opposite 
effect.  Although not reaching statistical significance, when analyzed separately by sex, there is 
modest evidence that the miR-138-injected mice consume less nicotine.  It remains unclear what 
the underlying mechanisms contributing to this effect may be.  One possibility is the overall 
alteration of nAChR stoichiometry upon miR-138 injection (Taki, Pan, and Zhang, 2014). 
Altering the configuration of the receptor may lead to a decrease in binding capability for the 
nicotine. Without nicotine binding, the mice would not experience the release of dopamine and 
the effects of the reward pathway that the nAChRs trigger (Antolin-Fontes et al., 2014).  
Limitations  
It is important to note that miRNAs have multiple mRNA targets and are often a part of 
transcriptional regulatory loops, and thus we cannot rule out the possibility that miR-138 has 
transcript targets other than the β4 subunit. MiRNAs may also result in subtle phenotypes 
making it difficult to distinguish behavior solely caused by the nicotine and not due to the 
microRNA (Coolen and Bally-Cuif, 2009).  
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 Future directions  
The next step in this study is to add animals to the subgroups and to confirm that our 
microinjections into the medial habenula are in fact in the medial habenula.  Brains from all mice 
have been removed postmortem and will be sliced for immunohistochemical verification of the 
virus injection site. Data from animals where the medial habenula was missed will be removed 
from analysis. 
A tanstant study will also be run in a separate cohort of mice to ensure that miR-138 does 
not affect nicotine consumption/preference based on taste alone. Mice will again be injected with 
miR-138 or a control and then tested for saccharin (sweet) and quinine (bitter) preference.  
Interestingly, miRNA-138 has also been associated with learning and memory. A recent 
paper showed that miR-138 injected into the hippocampus resulted in improved short term 
memory in mice (Tarto et al.,2013).  The medial habenula is also implicated with learning and 
memory, as it is the site where learned information is stored. Future studies should focus on 
examining the role of miR-138 in drug reward memories, as learning and memory plays an 
important role in maintaining nicotine dependence (Gould et al., 2006).  
Summary and Conclusions  
In summary, we observed an overall decrease in nicotine consumption and preference 
within the miRNA-138 treated mice. Our findings did not support our initial hypothesis that we 
would see an increase in nicotine preference. However, the fact that our preliminary results show 
an effect of the miRNA is very interesting so future work aimed at understanding the 
mechanisms will be important.   
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